USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 181 filers reported holding USANA HEALTH SCIENCES INC in Q3 2021. The put-call ratio across all filers is 2.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,222,895 | -9.1% | 20,865 | -2.2% | 0.00% | -33.3% |
| Q2 2023 | $1,345,587 | -37.1% | 21,345 | -37.5% | 0.00% | -25.0% |
| Q1 2023 | $2,140,356 | -2.2% | 34,129 | -16.4% | 0.00% | -20.0% |
| Q4 2022 | $2,187,638 | -24.6% | 40,844 | -20.4% | 0.01% | -16.7% |
| Q3 2022 | $2,900,000 | -43.5% | 51,323 | -27.3% | 0.01% | -40.0% |
| Q2 2022 | $5,129,000 | -18.0% | 70,615 | -10.4% | 0.01% | -9.1% |
| Q1 2022 | $6,257,000 | -31.0% | 78,780 | -12.0% | 0.01% | -21.4% |
| Q4 2021 | $9,064,000 | +8.5% | 89,561 | -1.5% | 0.01% | 0.0% |
| Q3 2021 | $8,353,000 | -31.7% | 90,946 | -24.0% | 0.01% | -30.0% |
| Q2 2021 | $12,226,000 | -7.3% | 119,591 | -11.6% | 0.02% | -13.0% |
| Q1 2021 | $13,186,000 | +15.9% | 135,321 | -8.4% | 0.02% | 0.0% |
| Q4 2020 | $11,378,000 | -14.8% | 147,704 | -19.3% | 0.02% | -20.7% |
| Q3 2020 | $13,355,000 | +10.2% | 183,102 | +9.3% | 0.03% | +7.4% |
| Q2 2020 | $12,115,000 | +42.5% | 167,570 | +14.1% | 0.03% | +22.7% |
| Q1 2020 | $8,500,000 | -26.2% | 146,872 | +0.1% | 0.02% | +4.8% |
| Q4 2019 | $11,517,000 | +37.2% | 146,661 | +20.8% | 0.02% | +31.2% |
| Q3 2019 | $8,397,000 | -8.6% | 121,389 | +1.3% | 0.02% | -5.9% |
| Q2 2019 | $9,186,000 | -25.3% | 119,802 | -18.8% | 0.02% | -26.1% |
| Q1 2019 | $12,304,000 | -26.4% | 147,527 | +1.7% | 0.02% | -37.8% |
| Q4 2018 | $16,725,000 | -27.2% | 145,003 | -23.7% | 0.04% | -15.9% |
| Q3 2018 | $22,980,000 | +57.0% | 189,942 | +49.9% | 0.04% | +41.9% |
| Q2 2018 | $14,639,000 | +24.1% | 126,695 | -7.9% | 0.03% | +55.0% |
| Q1 2018 | $11,800,000 | +156.4% | 137,522 | +123.4% | 0.02% | +150.0% |
| Q4 2017 | $4,603,000 | +211.9% | 61,570 | +140.7% | 0.01% | +166.7% |
| Q3 2017 | $1,476,000 | +5.4% | 25,577 | +17.1% | 0.00% | +50.0% |
| Q2 2017 | $1,400,000 | -12.0% | 21,841 | -20.9% | 0.00% | -33.3% |
| Q1 2017 | $1,591,000 | +3.6% | 27,619 | +11.8% | 0.00% | 0.0% |
| Q4 2016 | $1,535,000 | – | 24,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 23,547 | $2,383,000 | 1.99% |
| DENALI ADVISORS LLC | 21,013 | $2,127,000 | 0.80% |
| CLARK ESTATES INC/NY | 41,500 | $4,200,000 | 0.62% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 24,800 | $2,510,000 | 0.55% |
| HEARTLAND ADVISORS INC | 60,000 | $6,072,000 | 0.36% |
| ACADIAN ASSET MANAGEMENT LLC | 595,340 | $60,216,000 | 0.22% |
| CORNERCAP INVESTMENT COUNSEL INC | 12,870 | $1,302,000 | 0.19% |
| WINTON GROUP Ltd | 29,851 | $3,021,000 | 0.18% |
| Renaissance Technologies | 1,456,097 | $147,357,000 | 0.18% |
| Crew Capital Management, Ltd. | 2,000 | $202,000 | 0.17% |